Medicament for lct poisoning

Details Medicament for lct poisoning Medicament for lct poisoning

A - Human Necessities

61

K

A61K 31/04 (2006.01) A61K 31/661 (2006.01) A61K 31/6615 (2006.01) A61K 39/08 (2006.01)

Patent

CA 2659684

The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).

Médicament permettant d'éviter ou d'atténuer un empoisonnement dû à des cytotoxines de Clostridium de poids moléculaire élevé (Large Clostridial Cytotoxins / LCT), en particulier des cytotoxines A et B de Clostridium difficile (TcdA et TcdB). Ce médicament se caractérise en ce qu'il contient comme principe actif au moins un effecteur, à savoir un inhibiteur ou un activateur de l'activité de la protéase autocatalytique des LCT.

Affiliated with

Also associated with

Rating

Medicament for lct poisoning does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament for lct poisoning, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for lct poisoning will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1740746